The Diabetes Australian Research Program supports and develops outstanding diabetes research in Australia. We do this by funding a range of grants across the full spectrum of diabetes research through a merit based, competitive, peer review process. Research projects can focus on prevention, management of diabetes or the cure for diabetes.
There are two Millennium Awards of up to $150,000 awarded each year: one for type 1 diabetes and the other for type 2 diabetes.
2015 Millennium Award recipients
The 2015 Millennium Award – Type 1 was awarded to NSW based Dr Bruce King from the John Hunter Children's Hospital for research on the evaluation of an Australian artificial pancreas algorithm for announced and unannounced meals.
The 2015 Millennium Award – Type 2 was awarded to Victorian Dr Gwyneth Rees from the Centre for Eye Research Australia, for research on personalising eye consultations to improve outcomes in diabetic retinopathy. In addition to the Millennium Awards, General Grants (around $60,000 each) are also awarded to successful applicants.
2016 Millennium Award recipients
The 2016 Millennium Award- Type 1 was awarded to Dr Andrew Sutherland from St Vincent’s Institute of Medical Research (SVI), Melbourne.
In accepting the Millennium Type 1 Award, Dr Andrew Sutherland said, “Type 1 diabetes is an autoimmune disease that results in the destruction of pancreatic ß-cells which produce insulin. We are studying type 17 immune cells which may be involved in the damage to the pancreas and we hope to provide new targets for therapeutic intervention to prevent type 1 diabetes.”
The 2016 Underworks Millennium Award- Type 2 was awarded to Dr Muh Geot Wong of the Kolling Institute of Medical Research in Sydney. Dr Muh Geot Wong's research focuses on preventing kidney disease complications.
“People living with diabetes are at serious risk of complications including kidney disease. Diabetes is one of the leading causes of kidney damage leading to dialysis. In this study, our aim is to identify blood markers that enable clinicians to identify patients with type 1 and type 2 diabetes who are at highest risk of developing end stage kidney disease so that early intervention and targeted therapy can be focused on these people” said Dr Wong.
Learn more about:
Support Diabetes Australia Research Program
The Diabetes Australia Research Program relies on the generosity and support of member organisations, corporates and individual donors. Every extra dollar ensures more vital research is undertaken. You can support Diabetes Australia Research by way of tax deductible donations, estates or sponsorships.